Epstein Secrets

e Court's dictate in Amgen that a court should engage the merits of a claim only to the extent necessary to verify that Rule 23 has been satisfied. Amgen, 133 S. Ct. at 1194-95. Brown I did precisely that. 1. Even evaluated in a still more painstaking manner, the workers' statistical evidence is me

its of appellants' claim at this stage would be improper." Id. at 156. Such a statement, however, is consistent with the Supreme Court's dictate in Amgen that a court should engage the merits of a claim only to the extent necessary to verify that Rule 23 has been satisfied. Amgen, 133 S. Ct. at 1194-9

d Rodriguez v. Nat'l City Bank, 726 F.3d 372, 384-85 (3d Cir. 2013); Morgan v. United Parcel Serv. of Am., Inc., 380 F.3d 459, 468 (8th Cir. 2OO4); Munoz v. Orr, 200 F.3d 291, 301 (5th Cir. 2000); Sheehan v. Daily Racing Form, Inc., 104 For internal use only SDNY_GM_00056859 CONFIDENTIAL - PURSUANT

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

roughly a half a trillion dollars. ... The thought that Senate Republicans would go up to 2.2 trillion is outlandish." The Washington Times (9/30, Munoz, 492K) says McConnell "dismiss[edJ" House Democrats' measure as "unserious." He said, "House Democrats are trying to save face by introducing yet a

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

roughly a half a trillion dollars. ... The thought that Senate Republicans would go up to 2.2 trillion is outlandish." The Washington Times (9/30, Munoz, 492K) says McConnell "dismiss[ed]" House Democrats' measure as "unserious." He said, "House Democrats are trying to save face by introducing yet a

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

roughly a half a trillion dollars. ... The thought that Senate Republicans would go up to 2.2 trillion is outlandish." The Washington Times (9/30, Munoz, 492K) says McConnell "dismiss[ed]" House Democrats' measure as "unserious." He said, "House Democrats are trying to save face by introducing yet a